101 results
Page 3 of 6
8-K
EX-99.1
ou9xs78k
24 May 23
Microbot Medical Announces $2.66 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:32pm
424B5
j1qg9oo jz2
24 May 23
Prospectus supplement for primary offering
11:15am
8-K
EX-99.2
w2frsrpfobwjf8gk6e4k
23 May 23
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-99.1
hsq0e3f48hfpk5nohncd
23 May 23
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:05pm
424B5
2i0o jvp0
23 May 23
Prospectus supplement for primary offering
12:55pm
8-K
EX-99.1
y35zal6rs hj60v
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-99.1
6cknbb745g10ooy4ay
18 May 23
Microbot Medical to Enhance Focus on its Core Business and Prioritize
9:30am
8-K
EX-99.1
4q2798pe
8 May 23
Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System
8:30am
8-K
EX-99.1
ue5iji0y8q
5 May 23
Microbot Medical Announces Final Data From Its Recent Animal Study
9:00am
8-K
EX-99.1
6d2dzbu5 xk87
3 May 23
Regulation FD Disclosure
9:00am
8-K
EX-99.1
nzoj9
14 Dec 22
Regulation FD Disclosure
9:12am
8-K
EX-99.1
qc9psh239an0ync vr3
8 Dec 22
Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel
7:10am
8-K
EX-99.1
l4fp0sp5tsbn5
18 Nov 22
Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance
9:08am
8-K
EX-99.1
ge1bajo
15 Nov 22
Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space
9:31am
8-K
EX-99.1
bupl t6jmd4d2
3 Nov 22
Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System
7:00am
8-K
EX-99.2
w864m1wqz wdw4hv
25 Oct 22
Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:00pm
8-K
EX-99.1
wvnocp0zv5imnxs
25 Oct 22
Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:00pm
424B5
kbb6z1xr8b ucm
24 Oct 22
Prospectus supplement for primary offering
4:30pm
8-K
EX-99.1
5q8i5s 6k9ltz
18 Oct 22
Microbot Medical Accomplishes the Next-Step in the Regulatory Process for the LIBERTY® Robotic System
8:45am